Donald C. Carpenter

618 total citations
12 papers, 515 citations indexed

About

Donald C. Carpenter is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Donald C. Carpenter has authored 12 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Donald C. Carpenter's work include Immune Response and Inflammation (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Cell Adhesion Molecules Research (3 papers). Donald C. Carpenter is often cited by papers focused on Immune Response and Inflammation (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Cell Adhesion Molecules Research (3 papers). Donald C. Carpenter collaborates with scholars based in United States, United Kingdom and Germany. Donald C. Carpenter's co-authors include Don E. Griswold, Edward F. Webb, Jerry L. Adams, Charles J. Kotzer, John C. Lee, Ruth R. Osborn, David C. Underwood, Douglas W.P. Hay, Steven Bochnowicz and Heath C. Thomas and has published in prestigious journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Journal of Controlled Release.

In The Last Decade

Donald C. Carpenter

12 papers receiving 503 citations

Peers

Countries citing papers authored by Donald C. Carpenter

Since Specialization

Citations

This map shows the geographic impact of Donald C. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald C. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald C. Carpenter more than expected).

Fields of papers citing papers by Donald C. Carpenter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald C. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald C. Carpenter. The network helps show where Donald C. Carpenter may publish in the future.

Co-authorship network of co-authors of Donald C. Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of Donald C. Carpenter. A scholar is included among the top collaborators of Donald C. Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald C. Carpenter. Donald C. Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Jakob Busch‐Petersen, Donald C. Carpenter, Miriam Burman, James J. Foley, (unknown), David Kilian, M Salmon, Ruth J. Mayer, John Yonchuk, Ruth Tal‐Singer	39
2	Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660) 2017 ·British Journal of Clinical Pharmacology ·Bruce E. Miller, Ruth J. Mayer, Navin Goyal, (unknown), Nigel Dallow, Malcolm Boyce, Donald C. Carpenter, (unknown), (unknown), Aili L. Lazaar	47
3	The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects 2015 ·BMC Pharmacology and Toxicology ·Bruce E. Miller, Sunil Mistry, Kevin Smart, Paul Connolly, Donald C. Carpenter, (unknown), Jackie C. Bloomer, Ruth Tal‐Singer, Aili L. Lazaar	45
4	T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice 2013 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Patricia L. Podolin, Joseph P. Foley, Donald C. Carpenter, Brian Bolognese, (unknown), Edward R. Long, Oliver J. Harrison, Patrick Walsh	32
5	Azepanone-based inhibitors of human cathepsin S: Optimization of selectivity via the P2 substituent 2011 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey K. Kerns, Hong Nie, William E. Bondinell, Katherine L. Widdowson, Dennis S. Yamashita, A. H. ABD EL RAHMAN, Patricia L. Podolin, Donald C. Carpenter, Qi Jin, (unknown), Xiaoyang Dong, Neysa Nevins, Paul M. Keller, (unknown), Thaddeus A. Tomaszek	10
6	Inhibition of Invariant Chain Processing, Antigen-Induced Proliferative Responses, and the Development of Collagen-Induced Arthritis and Experimental Autoimmune Encephalomyelitis by a Small Molecule Cysteine Protease Inhibitor 2008 ·The Journal of Immunology ·Patricia L. Podolin, Brian Bolognese, Donald C. Carpenter, Talisha Davis, Roy A. Johanson, (unknown), Edward R. Long, Xiaoyang Dong, Robert W. Marquis, (unknown), Gerald Terfloth, Edit Kurali, John J. Peterson, Brian R. Smith, Michael S. McQueney, Dennis S. Yamashita, (unknown)	16
7	A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: Upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist 2006 ·Pulmonary Pharmacology & Therapeutics ·Grant C. Nicholson, Rachel Tennant, Donald C. Carpenter, Henry M. Sarau, Onn Min Kon, Peter J. Barnes, M Salmon, Rupert Vessey, Ruth Tal‐Singer, Trevor T. Hansel	41
8	Local Delivery of a Hydrophobic Heparin Reduces Neointimal Hyperplasia After Balloon Injury in Rat Carotid but not Pig Coronary Arteries 2001 ·Journal of Cardiovascular Pharmacology and Therapeutics ·Brett Sasseen, Brian D. Gray, (unknown), (unknown), Donald C. Carpenter, Bruce D. Klugherz, Robert L. Wilensky	7
9	Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation 2000 ·Journal of Immunological Methods ·Hugh M. Davis, Donald C. Carpenter, (unknown), (unknown), (unknown), Don E. Griswold	22
10	SB 239063, a Potent p38 MAP Kinase Inhibitor, Reduces Inflammatory Cytokine Production, Airways Eosinophil Infiltration, and Persistence 2000 ·Journal of Pharmacology and Experimental Therapeutics ·David C. Underwood, Ruth R. Osborn, Charles J. Kotzer, Jerry L. Adams, John C. Lee, Edward F. Webb, Donald C. Carpenter, Steven Bochnowicz, Heath C. Thomas, Douglas W.P. Hay, Don E. Griswold	216
11	Zyn-Linked colchicines: Controlled-release lipophilic prodrugs with enhanced antitumor efficacy 1996 ·Journal of Controlled Release ·Margaret Baker, Brian D. Gray, Betsy M. Ohlsson‐Wilhelm, Donald C. Carpenter, Katharine A. Muirhead	15
12	Modulation of HLA-DR Expression in Epithelial Cells by Interleukin 1 and Estradiol-17β* 1990 ·The Journal of Clinical Endocrinology & Metabolism ·Siamak Tabibzadeh, (unknown), Donald C. Carpenter, Betsy M. Ohlsson‐Wilhelm, P.G. Satyaswaroop	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact